Correction: Novel engineered IL-2 Nemvaleukin alfa combined with PD1 checkpoint blockade enhances the systemic anti-tumor responses of radiation therapy.
Kewen HeNahum Puebla-OsorioHampartsoum B BarsoumianDuygu SezenZahid RafqThomas S RiadYun HuAiling HuangTifany A VossClaudia S Kettlun LeytonLily Jae SchudaEthan HsuJoshua HeiberMaria-Angelica CortezJames W WelshPublished in: Journal of experimental & clinical cancer research : CR (2024)